Hu et al11 demonstrated that there were 64 (1.03%) carriers of BRCA1 and BRCA2 pathogenic germline variants in 6220 Chinese non‐small cell lung cancer (NSCLC) patients, with BRCA2 variants being the most predominant. Here, BRCA2 is linked to lung cancer.